This trial will use a PET scanner to test an improved method for differentiating tumor recurrence from radiation necrosis in glioblastoma patients. The new quantitative kinetic analytical methods using FDOPA in combination with FDG will provide crucial functional information to distinguish recurrent tumors from treatment-induced radiation changes in patients with treated brain neoplasms.
5 Primary · 0 Secondary · Reporting Duration: Up to 6 months
5 Total Participants · 1 Treatment Group
Primary Treatment: Multiparametric Magnetic Resonance Imaging Scan · No Placebo Group · Phase < 1
Age 18+ · All Participants · 7 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: